Project Grant R03AG087445
- This Project Grant award of $353,391.00, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate the use of a "Personal Learning Curve" paradigm as a sensitive marker of early memory decline related to Alzheimer's disease (AD) biomarkers in a large, diverse sample of older adults. The study seeks to determine if this digital cognitive assessment tool, which measures learning over repeated evaluations, can detect subtle AD-related memory failures...
- Grant Summary: Activities4Care Digital Platform Plans4Care Inc. received a $490,262 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on June 15, 2025, with completion targeted for May 31, 2026. The award funds development and testing of Activities4Care, a digital platform designed to address the critical unmet need for meaningful activities among the 6+ million individuals living with Alzheimer's disease and Alzheimer's disease-related...
- This Project Grant award of $4,787,820.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to gain a better understanding of the individual- and system-level characteristics that influence diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD), and how diagnosis can moderate the effects of cognitive decline on employment, future care, and quality of life. The key objectives are to: 1) examine whether older adults experiencing...
- Aster Labs, Inc. received a $499,943 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) with an award date of September 15, 2025, and a completion date of August 31, 2026. The company will design and construct a novel, unobtrusive wearable device capable of continuously measuring and analyzing gait patterns in older Black adults with Alzheimer's disease and related dementias (ADRD). This precision monitoring system addresses a critical...
- This $2,366,213 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund the INLIFE (Individualized Lifestyle Change for Every Aging Brain) study. The study aims to harmonize and analyze participant-level data from 12 U.S. randomized controlled trials to examine how changes in lifestyle behaviors such as physical activity, cognitive activity, diet, and social engagement impact cognitive outcomes across diverse older adult populations....
- Federal Grant Award Summary The National Institute on Aging awarded a $441,612 Project Grant to Boston University Medical Campus effective May 15, 2025, under the Aging Research program (CFDA 93.866) to investigate the relationship between modifiable lifestyle risk factors and digital cognitive markers in Alzheimer's disease progression. The research leverages the Framingham Heart Study's multi-generational cohort to develop and validate digital cognitive assessment methods—including digital pen...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
- Federal Project Grant Award Summary The National Institute on Aging awarded The Washington University a $730,089 Project Grant effective June 1, 2025, under the Aging Research program (CFDA 93.866) to conduct the Life-Space, Isolation, and Functional Exposome Study in Preclinical Alzheimer's Disease and Cognitive Environments (LIFESPACE). This five-year research initiative, concluding February 28, 2030, will develop and validate digital biomarkers and behavioral signals derived from everyday...
- COMTAD Federal Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $589,614 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective February 1, 2026, through December 31, 2030. The Cognitive Monitoring During Treatment for Alzheimer Disease (COMTAD) study will develop and validate a cognitive safety monitoring system to detect adverse side effects of anti-amyloid therapy in Alzheimer's...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Boston University Medical Campus a $327,000 project grant under the Aging Research program (CFDA 93.866) to identify clinically relevant cognitive subtypes in preclinical Alzheimer's disease using digital phenotyping methods. The research integrates multimodal data from traditional neuropsychological testing and digital voice recordings to develop computational models that characterize heterogeneous cognitive...
TEMPORAL DYNAMICS AND ASSOCIATIONS OF DEVICE-BASED ACTIVITY DISTRIBUTION METRICS AND EVERYDAY COGNITION IN OLDER ADULTS - THE ESCALATING INCIDENCE OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD) PLACES A TREMENDOUS ECONOMIC BURDEN ON SOCIETY AND FAMILIES ACROSS THE GLOBE. TO DATE, MEDICAL APPROACHES FOR PREVENTING AND TREATING AD/ADRD HAVE YIELDED LIMITED SUCCESS. PREVENTIVE STRATEGIES, SUCH AS PHYSICAL ACTIVITY, HOLD PROMISE FOR SUSTAINING COGNITION AND THUS REDUCING AD/ADRD RISKS IN OLDER ADULTS. HOWEVER, THIS LITERATURE HAS FOCUSED EXCLUSIVELY ON THE EFFECTS OF THE TOTAL AMOUNT OF TIME OR VOLUME OF HIGHER-INTENSITY PHYSICAL ACTIVITY (OR EXERCISE) ON COGNITIVE HEALTH. BEYOND THE TOTAL VOLUME AMOUNT PERFORMED, OLDER ADULTS ACCUMULATE THEIR PHYSICAL ACTIVITY THROUGH IRREGULAR LIFESTYLE ACTIVITY BOUTS (E.G., INTERMITTENT SHORT PERIODS OF WALKING ACTIVITIES) THROUGHOUT THE DAY. HOW THESE LIFESTYLE ACTIVITY BOUTS ARE ACCUMULATED AND ALLOCATED FROM DAY-TO-DAY MAY REPRESENT A SCALABLE AND RELATIVELY MORE ACHIEVABLE BEHAVIORAL TARGET THAT MAY GENERATE COGNITIVE BENEFITS. WHEN OLDER ADULTS' COGNITION IS SUSTAINED ON A DAILY BASIS WITHOUT DRASTIC VARIATIONS OVER TIME, THEIR RISKS FOR DEVELOPING AD/ADRD CAN BE REDUCED AS A RESULT. THUS, THE PROPOSED STUDY IS DESIGNED TO BRIDGE THE KNOWLEDGE GAP BY DETERMINING WHETHER THE DISTRIBUTION OF LIFESTYLE PHYSICAL ACTIVITY BOUTS IS ASSOCIATED WITH THE MEAN LEVEL AND THE VARIABILITY IN OLDER ADULTS' DAILY COGNITIVE FUNCTION. THIS STUDY WILL LEVERAGE MOBILE TECHNOLOGY TO COLLECT DATA ON DAILY PHYSICAL ACTIVITY BOUTS AND DAILY COGNITIVE FUNCTION USING A RESEARCH-GRADE ACCELEROMETER AND VALIDATED COGNITIVE ASSESSMENT SMARTPHONE APP. TO ACHIEVE OUR STUDY OBJECTIVES, WE WILL RECRUIT OLDER ADULTS WHO HAVE HIGHER RISKS FOR DEVELOPING AD/ADRD AND WILL REPEATEDLY MEASURE THEIR DAILY PHYSICAL ACTIVITY BOUTS AND PERFORMANCE- BASED COGNITIVE FUNCTION. A TOTAL OF 84 HIGH-RISK OLDER ADULTS (AGES 60+, 40% AFRICAN AMERICAN OR OTHER RACES BESIDES WHITE/NON-HISPANIC) WILL BE RECRUITED FROM THE LOCAL COMMUNITY. ELIGIBLE PARTICIPANTS WILL WEAR THE LIGHTWEIGHT ACTIVPAL ACCELEROMETER FOR 21 DAYS TO CAPTURE THE DISTRIBUTION OF THEIR DAILY BOUTS OF PHYSICAL ACTIVITY. DURING THE SAME 21-DAY PERIOD, THEY WILL ALSO COMPLETE UP TO FIVE ULTRA-BRIEF COGNITIVE TESTS DELIVERED BY THE NIH-FUNDED M2C2 APP DURING WAKING TIME EACH DAY. WE WILL APPLY INTENSIVE LONGITUDINAL DATA ANALYSIS VIA AN NIH-FUNDED STATISTICAL PROGRAM TO ANSWER OUR RESEARCH QUESTIONS. THIS STUDY WILL DETERMINE IF SPECIFIC DISTRIBUTIONS OF LIFESTYLE PHYSICAL ACTIVITY BOUTS REPRESENT A PROMISING BEHAVIORAL TARGET THAT CAN BE ENGAGED IN FUTURE EFFICACY TRIALS FOR SUSTAINING COGNITIVE HEALTH IN EVERYDAY LIFE. FINDINGS WILL ALSO PROVIDE AN EVIDENCE- BASED FOUNDATION FOR ADVANCING ADRD PREVENTIVE SCIENCE TO REDUCE AD/ADRD RISKS OR SLOWING DOWN THE PATHOLOGICAL PROCESS DURING THE LONG PRE-CLINICAL AD/ADRD PHASE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $287.4k | 4/19/24 |